Skip to main content

HNPCC - Change the Name to Protect the Innocent

This article has been published in the most recent edition of the Med Surg Nursing Journal. The article will be attached as a downloadable file in the very near future.

This is an article that was a tribute to my mom. Her wish was to have me continue the journey of educating people on this genetic form of cancer. This article is just one more step in that journey.

Comments

ivy.razmus said…
http://www.medsurgnursing.net/08dec/400.pdf
ivy.razmus said…
www.myriadtests.com/colorectal_hnpcc.htm
ivy.razmus said…
Lynch is a better name....
ivy.razmus said…
www.ahrq.gov/clinic/tp/hnpcctp.htm
Even government agencies are recognizing the need for safe care for people with Lynch/HNPCC.
ivy.razmus said…
E-mail: ivy.razmus@gmail.com
WWW.HNPCC.BLOGSPOT.COM W W W . H N P C C I N F O . B L O G S P O T . C O M
H N P C C I S A
H E R E D I T Y
F O R M O F
C O L O N
C A N C E R T H A T C A N
B E P A S S E D
T H R O U G H
G E N E R A T I O N S O F
F A M I L Y
U N D E T E C T E D
Bethesda Guidelines:
Tumors from any of the following
should be tested for MSI
Modified Bethesda II Guidelines
/ Amsterdam criteria
II:
All of the following must apply
for a putative diagnosis
of HNPCC to be made in a family—
• Individuals with cancer in families
that meet the Amsterdam Criteria.
• Individuals with two HNPCC associated
cancers, including synchronous
and meta-chronous CRC or
associated extra-colonic cancers
• Individuals with CRC and a firstdegree
relative with CRC and /or
HNPCC related extra-colonic cancer
and/or colorectal carcinoma
diagnosed < 40 yrs of age.
• Individuals with CRC or endometrial
cancer diagnosed < 45 yrs
of age.
• Individual with right sided CRC
and an undifferentiated pattern
(solid or cribriform) on histology
diagnosed < 45 yrs.
• Individuals with signet –ringcell-
type CRC diagnosed at age <
45 yrs.
• Individuals with adenomas diagnosed
at age < 40
yrs.
T E S T I N G
G U I D E L I N E S F O R
H N P C C
M A R G A R E T C O O K S W A N S O N
C O L O N C A N C E R A W A R E N E S S
Bringing Awareness to HNPCC
Genetic Colon Cancer
M A R G A R E T C O O K S W A N S O N
C O L O N C A N C E R A W A R E N E S S
• Individuals with cancer in families
that meet the Amsterdam criteria
• Individuals with two HNPCC associated
cancers, including synchronous andmetachronous
CRC or associated extracolonic
cancers
• Individuals with CRC and a first degree
relative with CRC and or HNPCC related
extra-colonic cancer and or a colorectal
adenoma diagnosed at age < 40 yrs
• Individuals with CRC or endometrial
cancer diagnosed at age < 45 yrs
• Individuals with Signet Ring cell type
CrC diagnosed at age < 45 yrs
• Individuals with adenomas diagnosed at
age < 40 yrs
• At least three relatives with an HNPCC
associated cancer (large bowel, endometrial,
small bowel, ureter, or renal
pelvis though not including stomach,
ovary, brain, bladder or skin.
• One affected person is a first degree
relative of the other two relatives
• At least two successive generations are
affected
• At least one person was diagnosed before
the age of 50 yrs
• Familial adenomatous polyposis has been
excluded
• Tumors have been verified by pathologic
examination

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...